Premium
A case of pediatric PTLD following autologous stem cell transplantation and review of the literature
Author(s) -
Eckrich Michael J.,
Frangoul Haydar,
Knight Jennifer,
Mosse Claudio,
Domm Jennifer
Publication year - 2012
Publication title -
pediatric transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 69
eISSN - 1399-3046
pISSN - 1397-3142
DOI - 10.1111/j.1399-3046.2010.01382.x
Subject(s) - medicine , rituximab , prednisone , cyclophosphamide , autologous stem cell transplantation , adverse effect , transplantation , disease , pediatrics , surgery , lymphoma , chemotherapy
Eckrich MJ, Frangoul H, Knight J, Mosse C, Domm J. A case of pediatric PTLD following autologous stem cell transplantation and review of the literature.
Pediatr Transplantation 2012: 16: E15–E18. © 2010 John Wiley & Sons A/S. Abstract: The development of PTLD is a rare severe adverse event following ASCT. We report on a child with DS who developed PTLD following autologous transplant for relapsed Hodgkin’s disease. He was successfully treated with cyclophosphamide, prednisone and rituximab. We also present a comprehensive review of the literature of PTLD in pediatric patients following ASCT.